Reflect Scientific Inc
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as f… Read more
Reflect Scientific Inc (RSCF) - Net Assets
Latest net assets as of September 2024: $2.08 Million USD
Based on the latest financial reports, Reflect Scientific Inc (RSCF) has net assets worth $2.08 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.34 Million) and total liabilities ($258.55K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.08 Million |
| % of Total Assets | 88.94% |
| Annual Growth Rate | -6.57% |
| 5-Year Change | 242.22% |
| 10-Year Change | N/A |
| Growth Volatility | 386.68 |
Reflect Scientific Inc - Net Assets Trend (2006–2023)
This chart illustrates how Reflect Scientific Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Reflect Scientific Inc (2006–2023)
The table below shows the annual net assets of Reflect Scientific Inc from 2006 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $1.89 Million | -17.59% |
| 2022-12-31 | $2.30 Million | +5.36% |
| 2021-12-31 | $2.18 Million | +79.67% |
| 2020-12-31 | $1.21 Million | +119.36% |
| 2019-12-31 | $553.03K | +6.81% |
| 2018-12-31 | $517.74K | +13.68% |
| 2017-12-31 | $455.43K | -20.31% |
| 2016-12-31 | $571.49K | +3.03% |
| 2015-12-31 | $554.70K | +197.91% |
| 2014-12-31 | $-566.53K | -13.45% |
| 2013-12-31 | $-499.36K | -1487.11% |
| 2012-12-31 | $36.00K | +110.06% |
| 2011-12-31 | $-358.00K | -180.09% |
| 2010-12-31 | $447.00K | -79.30% |
| 2009-12-31 | $2.16 Million | -66.07% |
| 2008-12-31 | $6.36 Million | -22.80% |
| 2007-12-31 | $8.24 Million | +37.15% |
| 2006-12-31 | $6.01 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Reflect Scientific Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1926674700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $21.16 Million | 1118.02% |
| Total Equity | $1.89 Million | 100.00% |
Reflect Scientific Inc Competitors by Market Cap
The table below lists competitors of Reflect Scientific Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Appili Therapeutics Inc
PINK:APLIF
|
$1.73 Million |
|
TAQA MOROCCO
BC:TAQA-MOROCCO
|
$1.73 Million |
|
Valhalla Metals Inc.
OTCQB:VMXXF
|
$1.73 Million |
|
Welltower OP LLC
STU:HCW
|
$1.73 Million |
|
Revelation Biosciences Inc
NASDAQ:REVB
|
$1.72 Million |
|
AMETEK
BE:AK1
|
$1.72 Million |
|
Franklin Mining Inc
PINK:FMNJ
|
$1.72 Million |
|
Pasukhas Group Bhd
KLSE:0177
|
$1.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Reflect Scientific Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,296,602 to 1,892,574, a change of -404,028 (-17.6%).
- Net loss of 459,028 reduced equity.
- Other factors increased equity by 55,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-459.03K | -24.25% |
| Other Changes | $55.00K | +2.91% |
| Total Change | $- | -17.59% |
Book Value vs Market Value Analysis
This analysis compares Reflect Scientific Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.95x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-0.01 | $0.04 | x |
| 2014-12-31 | $-0.01 | $0.04 | x |
| 2015-12-31 | $0.01 | $0.04 | x |
| 2016-12-31 | $0.01 | $0.04 | x |
| 2017-12-31 | $0.01 | $0.04 | x |
| 2018-12-31 | $0.01 | $0.04 | x |
| 2019-12-31 | $0.01 | $0.04 | x |
| 2020-12-31 | $0.01 | $0.04 | x |
| 2021-12-31 | $0.03 | $0.04 | x |
| 2022-12-31 | $0.03 | $0.04 | x |
| 2023-12-31 | $0.02 | $0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Reflect Scientific Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -24.25%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -42.50%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.41x
- Recent ROE (-24.25%) is below the historical average (48.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 558.33% | 15.12% | 1.00x | 36.75x | $197.40K |
| 2013 | 0.00% | -78.51% | 1.50x | 0.00x | $-963.26K |
| 2014 | 0.00% | -55.03% | 1.81x | 0.00x | $-784.16K |
| 2015 | 150.70% | 80.59% | 1.47x | 1.27x | $780.47K |
| 2016 | -37.83% | -18.19% | 1.89x | 1.10x | $-273.34K |
| 2017 | -88.31% | -37.74% | 1.84x | 1.27x | $-447.73K |
| 2018 | -48.19% | -16.08% | 2.62x | 1.14x | $-301.30K |
| 2019 | -35.37% | -12.15% | 1.49x | 1.95x | $-250.89K |
| 2020 | 54.41% | 23.64% | 1.67x | 1.38x | $538.80K |
| 2021 | 43.08% | 33.36% | 1.14x | 1.14x | $721.09K |
| 2022 | 3.89% | 4.38% | 0.83x | 1.07x | $-140.26K |
| 2023 | -24.25% | -42.50% | 0.40x | 1.41x | $-648.29K |
Industry Comparison
This section compares Reflect Scientific Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Reflect Scientific Inc (RSCF) | $2.08 Million | 558.33% | 0.12x | $1.73 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |